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Abstract:  Quality assessment in kidney transplantation involves inspection to 
identify negative markers of organ-quality. However, there is a paucity of evidence 
guiding surgical appraisal, and currently there is no evidence to differentiate 
important features from those that can be safely ignored. We propose a method to 
standardise surgical assessment and derived a simple rule to rapidly identify kidneys 
suitable for transplantation. 
Donor and recipient data were recorded alongside clinical outcomes in a 
prospectively maintained database. We developed a proforma (Cambridge Kidney 
Assessment Tool, CKAT) and used it to assess deceased-donor kidney transplants. 
Factors predictive of utilisation were identified by multivariate and univariate logistic 
regression analysis of CKAT-assessment scores, and test performance was 
evaluated using standard 2x2 contingency tables. 
97 kidneys were included at a single centre (2013-2014), 184 CKAT-assessments 
were performed. A CKAT-threshold of ‘Carrell+Perfusion>3’, was highly specific 
(99%) and performed favourably to consultant opinion (specificity 95%). 96% of the 
kidneys implanted in accordance with the rule survived to 1-year (mean eGFR 
45.3ml/min/1.73m2). 
To our knowledge, this is the first attempt to objectively define macroscopic features 
that are relevant to kidney utilisation. Common language could support training in 
organ assessment and ultimately help address unnecessary discard of donor 
kidneys. 
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Kidney transplantation is the gold standard treatment for End Stage Renal Disease, 
yet in the UK, patients wait an average of 3 years for a transplant. During this time, 
12% of registered patients either become too unwell or die before they have their 
operation1. Despite this, 10-12% of donor kidneys are deemed unsuitable for 
transplantation following assessment by clinicians, and estimates for organ discard 
are even higher in the USA2,3. Whilst a small proportion of discards are due to an 
absolute contraindication to transplantation (e.g. malignancy), four of the top five 
reasons for discard are due to the team’s assessment of organ quality2. Currently, 
quality assessment focusses on visual inspection to identify macroscopic features 
(e.g. perfusion characteristics) that, if present, are presumed to denote poorer quality 
grafts. Whether these features in fact have deleterious effects on transplant function 
has not been demonstrated conclusively. To complicate matters, organ assessment 
is not standardised, decision making - whilst challenging - is opaque, and therefore 
difficult to evaluate by external observers. With the introduction of the ‘Fast-track’ 
system in the UK, we now know that kidneys declined by five or more independent 
assessors can still be implanted, with comparable short-term results to standardly 
allocated organs4. Similarly, for unilateral kidney donors in the USA (where the 
paired kidney was declined by all transplant centres), kidneys still can provide good 
transplant outcomes5. Kidney assessment technologies (e.g. pre-implantation biopsy 
or ex-vivo machine perfusion) could enable clinicians to make more reliable 
assessments of organs after they are retrieved, but definitive evidence that these 
tests improve either the quality or numbers of kidney transplants is not yet at hand6,7.  
In any case, such technologies are not always widely available, and even when 
accessible, their use incurs additional time, logistical and financial costs.  
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Over the last 20 years, clinicians have gained access to large multicentre electronic 
databases, revealing population-based associations between donor risk factors (e.g. 
age, cardiovascular morbidity) and poorer transplant outcomes8,9. In comparison, 
there is a paucity of evidence guiding the surgical appraisal of kidneys for 
transplantation, and currently there is no evidence base to differentiate factors that 
should be relevant to utilisation decisions from those that can be safely ignored. The 
potential tools for appraisal of deceased donor kidneys were recently reviewed, and 
macroscopic assessment was identified as an area urgently requiring research to 
address the variability and validity of organ assessments10. Disturbingly, whilst the 
surgeon’s appraisal has a direct influence on organ utilisation, we have no evidence 
that independent assessors concur on assessment of organ quality parameters. A 
further complication is the fact that macroscopic appearances can evolve during the 
retrieval process, or during transport. Consequently, recipient centres often report 
discrepancies between their assessments of the organ after it arrives at their centre, 
with that of the retrieving surgeon(s). Significant discrepancy can mean that an organ 
is deemed unsuitable for its intended recipient and discarded. Although the extent of 
this problem is not well defined, as an indication, Callaghan and colleagues re-
evaluated 20 discarded kidneys in the UK to determine if local assessing surgeons 
agreed with the decision to discard a kidney made by another centre. The assessors 
disagreed with the decision to discard in 65% of cases, and the most common 
reason for discard in that series (15 of 20 kidneys) was “poor perfusion”2.  This 
suggests that inter-observer variability in assessment may contribute to 
misallocation, and/or unnecessary discard of kidney transplants. 
A possible solution is for surgeons to utilise agreed parameters for description of 
deceased donor kidneys. Aside from reducing inter-observer variability, a common 
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language would support training in organ assessment, aid reporting and comparative 
studies, and could be used as the basis for an objective appraisal tool. The ideal 
assessment tool would be quick and easy to use, have good intra- and inter-
observer concordance and should not rely significantly on user experience. As a tool 
to support organ selection, it should also have high positive and negative predictive 
values. If effective, organ utilisation could be rationalised without significant financial, 
logistical or time costs, and the tool could complement other assessment and 
allocation methods. This would be particularly beneficial for units that, for example, 
find the logistics of ex-vivo organ perfusion a challenge, or where there is limited 
access to a dedicated, integrated on-call histopathology service.  
Therefore, this study had two objectives. First, we aimed to move towards 
standardised language in the appraisal kidneys for transplantation by producing an 
objective, standardised assessment tool for surgeons to use whilst assessing organs 
for transplantation. We have named this the Cambridge Kidney Assessment Tool or 
CKAT. Second, we aimed to determine which macroscopic features are most 
relevant to utilisation decisions and use these to provide a simple assessment 
method that can support decision making in transplant kidney utilisation.  
Ethics 
Approved by Cambridge University Hospitals NHS Foundation Trust, Service 






MATERIALS AND METHODS 
 
Retrieval and allocation  
During the study period (2013-2014), 97 deceased donor kidneys were retrieved, 
accepted, and assessed for transplantation at our centre. Kidney procurement was 
performed as described previously11.  At the time of entry, kidneys from donors who 
had suffered irreversible, catastrophic brain injury sufficient to meet brain-death 
criteria (DBD), were allocated nationally by NHS Blood and Transplant (NHSBT), 
using an algorithm that incorporated HLA matching, time on the waiting list, level of 
sensitization to HLA and donor-recipient age difference12. Kidneys donated after 
circulatory death (DCD) were from Maastricht Category III donors13, and donation 
was pursued for 4 hours following the withdrawal of life sustaining treatment.  At the 
time of the study, a national sharing scheme had not yet not been implemented for 
DCD kidneys, and at least one kidney was retained by the local centre for a local 
recipient. Post-transplant care and immunosuppression were administered according 
to standard protocols, described more fully elsewhere14. 
Assessment process 
During the study period, absolute contraindications for acceptance of a kidney 
transplant were: active IV drug use at the time of offer and active HIV infection. 
Relative contraindications included: malignancy, age and cardiovascular co-
morbidity. Once the kidney arrived at our centre, kidneys from donors aged 60 years 
and over were biopsied and a Remuzzi score was assigned following 
histopathological assessment15. At the time of the study, kidneys scoring 1-3 were 
used as single transplants, 4-6 as duals, and those scoring 7 or more were 
discarded16–18. During preparation on the backbench, the implanting surgeon would 
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inspect the appearance of the kidney and evaluate its suitability for transplantation 
by integrating the results of the macroscopic assessment with all the information 
available from the donor’s clinical history and events that occurred during retrieval 
process. 
Appraisal method 
We consulted a group of experienced transplant surgeons at our centre to identify 
the range of macroscopic features relevant to organ utilisation decisions. An 
assessment proforma was devised which included all the relevant features [fig 1], 
and the proformas were made available to surgeons performing organ retrieval and 
backbench preparation of kidneys destined for implantation at our centre. Prior to the 
determination of suitability for transplant made by the implanting surgeon, retrieval 
surgeons were asked to assess the kidney individually, using the assessment 
proforma[fig 1]. They were therefore unblinded to the clinical history, donor 
characteristics, and operative findings; mirroring clinical practice[fig 2]. A small 
number of kidneys were subjected to pre-implantation biopsy assessment, however, 
the results of these tests were not known at the time of the proforma assessment. 
The suitability for transplantation was also assessed by an independent transplant 
consultant at our centre who was not part of the implanting team and who did not 
use the proforma. This consultant was also unblinded to the clinical history, donor 
characteristics, and operative findings, mirroring clinical practice. A summary of the 





Donor and recipient demographic data were recorded alongside clinical outcome 
data in a prospectively maintained database. Descriptive data were presented as 
number, median or percentage (categorical variables). Comparisons were made 
using the Kruskal-Wallis test (continuous variables), at a significance threshold of 
less than 0.05 for the p-value.  Factors important for predicting utilisation of 
transplant kidneys were identified using univariate and multivariate logistic 
regression analysis of the assessment scores, described more fully below. 
Evaluation of the appraisal methods (i.e. Consultant vs CKAT-based appraisal) 
employed standard statistical approaches to compare test performance: sensitivity; 
specificity; positive- and negative-predictive values. Estimated glomerular filtration 
rate (eGFR, mL/min/1.73m2) was calculated using the 4variable MDRD formula at 1-
year19. Graft survival is defined as time from transplant to graft failure (need for 
dialysis) censored for death with a functioning graft. Statistical tests were 
implemented using R Studio version 3.5.1 (2018) with the ‘tidyverse’ and ‘caret’ 







Donor and assessor demographics 
97 kidneys were included in this study, of which 90 were donated after circulatory 
death (DCD) whilst the remainder (n=7) were donated following the diagnosis of 
brain stem death (DBD). This reflects the fact that at the time of the study, at least 
one kidney from a DCD pair was retained by the local kidney transplant centre. 
Kidneys that were declined as unsuitable for transplantation prior to the arrival of the 
kidney back at base could not be included, as we required 3 independent 
assessments (retrieval surgeon, implanting surgeon and independent consultant) in 
our analysis. Exclusion from further analysis was therefore on the basis of: donor-
anatomical factors (n=1, severe pre-mortem aortic dissection), damage (n=0) 
malignancy or infection (n=2).  
In the UK the Consultant is a senior surgeon who has overall responsibility for the 
care of patients in hospital. The equivalent surgeon grade in the United States is 
Attending Surgeon. In the UK, a trainee is doctor who is pursuing a career in 
surgery. This includes those who are engaged in an official training programme, 
either at the core- (CT1-3), or specialty-trainee level (ST3-8). The workforce in 
Cambridge is international and welcomes many graduates from outside the UK 
whose training pathways do not map directly onto ours, as well as UK graduates 
outside the official training pathway. In this study, we have divided the grade of 
‘trainee’ into junior trainee (3-6 years post-graduation) and senior trainee (>6 years 
post-graduation) which better characterises the important distinctions in our unit.  
The equivalent training grade in the United States is Residency. 93% of initial 
proforma assessments in this study were performed by junior and senior trainees, 
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reflecting the staffing of the Cambridge organ retrieval team (NORS team) [tab 1B]. 
Summary statistics regarding donor demographics can be found in Table 1A [tab 
1A], which primarily reflects the DCD donor pool at the time of the study.   
Assessment scores 
184 assessments were made in total [tab 1B]. The median number of assessments 
per kidney was 2, and the maximum number of assessments was 4[fig 3]. The 
distribution of the scores for each assessment dimension can be seen in Figure 4[fig 
4]. The actual number of assessments for each kidney depended on the availability 
of the staff at the time of retrieval. If scores between assessors differed, we used a 
majority vote to determine the “aggregated” score in our analysis and in the event of 
a draw, we took the higher score as a cautious measurement. Other ways of 
aggregating scores are also possible, but sensitivity analysis did not reveal 
significant changes in results when these were applied. 
Inter-observer scoring using the proforma was highly consistent; in each dimension, 
no two assessors differed in their scoring of the kidney by more than 1 point on the 
rating scale.  
Statistical methods used to develop the assessment tool 
A two-stage decision procedure was proposed. In the first stage, we discarded all 
kidneys which were unusable prior to assessment due to donor-anatomy, damage, 
malignancy or infection (n=3) [fig 5]. In the second stage, we examined the recorded 
assessment scores. First, a univariate logistic regression analysis was used to 
identify the assessment characteristics that predicted utilisation, which then formed 
the basis of an assessment rule to guide organ selection. Of all the factors included 
in the proforma, three contributed to the predictive power of the logistic regression 
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model. They were quality of Carrell patch, extent of renal artery atherosclerosis and 
the kidney’s perfusion characteristics. We then applied multivariate logistic 
regression based on these scores. Carrell patch and perfusion characteristics shared 
similar coefficients, while renal artery atherosclerosis no longer conferred additional 
predictive power in the presence of the aforementioned factors. Consequently, we 
removed renal artery atherosclerosis and combined the Carrell patch and the 
perfusion characteristics into one new factor.  
This led to the decline rule of “Carrel patch quality + Perfusion quality > a threshold”.  
Determining the threshold and testing the rule 
To determine the appropriate threshold for decline of a kidney for transplantation, 
various rule thresholds were retrospectively applied and their performance compared 
against the implanting surgeon’s decision as the ‘gold-standard’. A 2x2 contingency 
table was constructed to demonstrate sensitivity, specificity, positive and negative 
predictive values for each threshold.  Based on this analysis, the best performing 
rule threshold for decline of a kidney for transplantation was: “Carrel patch quality + 
Perfusion quality >3”. A higher or a lower threshold would worsen the sensitivity or 
the specification of the rule. To allow comparison of performance with current 
standard procedure, we also compared the accuracy of chosen threshold rule (Carrel 
+ Perfusion >3) to the judgement of an independent, unblinded transplant consultant 
from our centre who was asked to assess the kidney and decide whether they 
thought the kidney was transplantable.  
Assessment tool performance 
Of the 94 kidneys that were included in the analyses, 73 were transplanted. Of 
these, 6 were implanted as part of a dual transplant, with the remainder implanted 
13 
 
singly [fig 5]. In cases where the Aortic patch was not used but the kidney was still 
transplanted, the anastomosis was end-to-side with interrupted sutures. Of the 21 
kidneys declined for transplantation by the implanting surgeon, in 7 cases the 
prediction of the independent consultant (sensitivity 33%) matched this outcome, 
whilst 9 were identified by the assessment tool (sensitivity 47%), these kidneys were 
not accepted for transplant by any other centre and were discarded. Of the 73 
kidneys that were ultimately transplanted, 69 were predicted by the independent 
consultant (specificity 95%), whilst 72 were identified by the assessment tool 
(specificity 99%).  
Of the 11 kidneys declined for transplantation by the independent consultant, 7 were 
in fact discarded (PPV 63%). In comparison, of the 10 kidneys declined by the 
assessment rule, 9 were discarded (PPV 90%). Of the 83 kidneys described as 
transplantable by the independent consultants, 69 were transplanted (NPV 83%), 
whilst of the 84 kidneys described as transplantable by the assessment rule, 72 were 
transplanted (NPV 86%). See Table 2 [tab 2]. 69 of the 72 kidneys implanted in 
accordance with the assessment rule survived the first year (96% 1-year graft 
survival) with a mean eGFR of 45.3ml/min1.73m2).  
We examined the cases where our assessment rule and the independent consultant 
made different decisions (n=7). Within these, our assessment rule correctly predicted 
the ultimate fate of the kidney in 6 cases (i.e. 4 implanted and 2 declined). Only one 
kidney was implanted that would not have been if the rule had been followed. At 1-








Neutral terms on rating scales are known to give a psychological benchmark that 
biases against discrimination, as when a middle option is offered, it is far more likely 
to be chosen20,21. Given that the aim of the appraisal process is to discriminate 
between organs that are fit for transplantation from those that are not, we omitted 
neutral categories where possible. Complex characteristics that could not be 
measured directly e.g. ‘mild- or moderate- atherosclerosis’ were benchmarked in 
plain English or given numerical thresholds to minimise subjectivity. This strategy 
appeared to be effective as ratings using the proforma were highly consistent. For all 
assessment categories, no two assessments of the same kidney deviated by more 
than 1-point on the rating scale, suggesting that the descriptors normalised language 
sufficiently to minimise inter-observer variability. 
Assessment scores 
First, we examined whether the distribution of scores was consistent with 
expectations for a cohort of kidneys that were predominantly transplantable. Scores 
relating to the size of the kidney appeared to be centrally placed and reasonably 
well-spread across the scale. However, as expected, there was significant skewness 
in the distributions of the other assessments denoting organ quality, so that most 
kidneys were scored as normal or only mildly suboptimal. This gives us confidence 
that the categories are appropriately sized and well placed. Next, we observed 
whether there was a relationship between the scores given using the assessment 
proforma and factors which are already known to affect organ quality, most important 
of which is donor age. We consistently found that whilst low scoring (close to 
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optimal) kidneys were retrieved from donors of any age, high scoring (e.g. >= 2) 
kidneys were from a comparatively narrower pool of exclusively older donors. This 
pattern was observed with respect to the Carrell patch and renal artery scoring, with 
the corresponding p-values 0.005 and 0.04 by the Kruskal–Wallis tests [fig 6]. 
No obvious relationship was observed between donor age and Remuzzi score (p-
value 0.91) [fig 7], nor were any of the macroscopic assessment scores able to 
reliably predict the biopsy score. The fact that we were unable to observe these 
relationships is difficult to interpret. However, we note that the availability - or 
otherwise - of biopsy scores was not random, since ‘good quality’ kidneys (based on 
clinical assessment), as well as kidneys from younger donors (typically aged <60 
years) were often simply transplanted and not biopsied. Furthermore, given that 
fewer than 100 kidneys were included in the study, the very small numbers of highly 
scoring kidneys likely limited our power to detect a relationship.  
Appraisal rule 
One aim of the study was to identify factors that reliably predicted organ utilisation 
within this cohort of donor kidneys. Following our analysis, we found two factors that 
were important, and we used these to form the basis of an easy to use, rapid organ 
assessment rule. Within our cohort of kidneys, the rule proposed to identify kidneys 
at higher risk of decline for transplantation was: “Carrel patch quality + Perfusion 
quality >3”, as it performed well in a retrospective 2x2 contingency table analysis.  
Importantly, by following this simple rule, assessments made by a mix of junior and 
senior transplant trainees were more accurate for predicting utilisation than an 
independent transplant consultant at our centre assessing the same kidney. The 
choice of an independent consultant at the same centre to compare test 
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performance was pragmatic, but also served as the strictest possible control, as 
many confounding factors such as local policy or ‘surgical culture’ would be shared. 
Despite this, and in keeping with what others have reported, surgeons – in this case, 
even from the same centre - do not always agree on whether a given kidney is 
suitable for transplant, further buttressing the case for an objective method of 
interrogating these differences of opinion2,22.  
Limitations 
This study has some important limitations which we hope to address in future work. 
A central issue that affects all studies of pre-implantation assessment methods is 
that there is currently no way of evaluating whether the ultimate decision to discard 
an organ is the correct one. In our series, we found 9 kidneys were predicted to be at 
high risk of discard by the CKAT appraisal rule that were ultimately discarded, 
compared to only 7 by the independent transplant consultant. However, it would be 
erroneous to assume that this increased sensitivity necessarily implies a better test, 
as that would depend on the outcomes of the kidneys had they been transplanted. 
Although this cannot be proved definitively in the absence of functional outcome 
measures in transplanted patients, further tests of ‘transplantability’ - like ex-vivo 
perfusion or pre-implantation biopsy - could be used in combination for kidneys 
deemed at higher risk of decline following macroscopic assessment, although this 
would depend on local availability and the outcomes of ongoing trials6,7,23. 
For logistical reasons, we required that surgeons from our centre retrieved, then 
implanted the kidney, and we were therefore only able to recruit a small number of 
kidneys over the 2-year study-period, limiting our power to detect potentially 
important associations. Entry was particularly difficult for DBD kidneys, as they were 
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nationally allocated at the time of the study, which meant that opportunities for 
multiple assessments (e.g. by retrieval, and implanting teams) were infrequent. 
Whilst it is entirely possible that the same macroscopic appearance in a DCD vs 
DBD kidney could have different implications for organ quality in each case, we feel 
that the overwhelming evidence from retrospective studies of organ outcome (as well 
as our own local experience) shows that DCD and DBD kidneys perform 
equivalently, and by extension should be utilised equivalently in the absence of 
strong evidence proving a difference16,24–27. Moreover, limited numbers meant that 
we had to develop and test the rule on the same cohort, so our proposed CKAT 
model risks overfitting our current dataset. Ultimately, these assumptions require 
testing in a large macroscopic assessment study to address these questions, due to 
lack of direct evidence in the area. In a future study, higher numbers could also 
enable us to interrogate the relationship between macroscopic features and biopsy-
based assessment, which to our knowledge, has not yet been described. 
Future considerations 
We found that kidneys that did not meet the CKAT score threshold (Carrel + 
Perfusion >3) were highly likely to be suitable for transplantation. Therefore, given 
the high specificity and negative predictive values observed at that threshold, 
kidneys scoring below the threshold could - in theory - be transplanted with 
confidence, without the need for additional tests that would incur additional delays 
and/or cost. However, to confirm this, we would need to validate the rule in a large 
prospective study, including assessors from a variety of transplant centres. In the 
UK, retrieval surgeons conform to centrally organised national standards28. A future 
study (justified by this experience) could leverage this national framework by 
routinely appraising kidneys using the CKAT proforma, whilst simultaneously 
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collecting outcome data via the UK Transplant Registry, following the template of 
other low-cost ‘registry-based trials’7. This would ensure that prior to clinical 
adoption, the threshold was validated robustly, this would need to include an 
evaluation of what impact macroscopic selection rules might have on overall kidney 
utilisation, as this would minimise the risk of a negative impact.  Whilst this study 
provides evidence that macroscopic assessment can be predictive of utilisation, 
long-term follow up will be essential to observe whether macroscopic appraisal can 
reliably predict future clinical transplant outcomes, or even whether selection 
thresholds defined today require future adjustment consequent to the impact of 
emerging technologies such as biopsy assessment, ex-vivo machine perfusion or 
medical management.  
It is also important to emphasise that kidneys assigned a CKAT-score in excess of 
the threshold should not be considered ‘untransplantable’, as the rule performed less 
well in predicting outcomes above the threshold. Instead, these kidneys are more 
likely to benefit from more intensive assessment, or further tests of transplantability 
dependent on local availability. The CKAT assessment tool could therefore be used 
to complement or rationalise the application of the other assessment techniques. 
The final decision to proceed with a transplant should always rest with the implanting 
team, taking into account both donor and recipient factors.  
The goal of the CKAT-score is not to supplant clinician decision making, but to begin 
the process of developing an evidence base on which determinations on organ 
quality reside. We would argue that, until we have a common, standardised 
language, the transplant community will continue to struggle to get the right organ to 
the right recipient. Similarly, until we can be confident that organ descriptors are 
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being used reliably by different surgeons, we cannot include these terms effectively 
in our models of organ risk or study their impacts robustly.   
In the future, many kidneys will have on-table photographic images taken at retrieval 
using mobile phones or tablets. Whilst this may reduce the implanting surgeon’s 
reliance on retrieval assessment, it continues the tradition of macroscopic appraisal 
being subjectively determined, albeit remotely. Future attempts to highlight and limit 
‘unnecessary discard’ of transplants will ultimately rely on a more universally 
accepted definition of an ‘ideal’ or ‘transplantable’ kidney.  Whilst known clinical and 
operative risk factors will certainly play a role, this definition will need to integrate the 
relevant aspects of macroscopic assessment, as these are part of quality-
assessment in clinical practice. Therefore, future work in minimising ‘unnecessary 
discard’ is likely to benefit from standardised descriptors of organ quality, potentially 






The purpose of this study was to move towards standardised language in the 
appraisal kidneys for transplantation by producing an objective (minimal inter-
observer variability), standardised assessment proforma for surgeons to use whilst 
assessing kidney transplants (CKAT). We also showed that a simple assessment 
rule (CKAT-score; Carrel + Perfusion >3) can predict utilisation more accurately than 
an unblinded, independent consultant transplant surgeon. To our knowledge, this is 
the first attempt to objectively identify macroscopic features that are relevant to 
utilisation. Additional benefits of the CKAT appraisal method are that it can be 
implemented without additional cost, assessment requires minimal prior transplant 













   Male 










Age, (median) years 62 61 69.5 
BMI, (median) kg/m^2 26.7 26.1 28.4 
Cardiovascular morbidity     
(HTN/Diabetes) 
17 (35%) 13 (32%) 6 (75%) 
Terminal creatinine 
(median) µmol/l 
76.5 74.5 95 
DCD 44 (95%) - - 
 
Table 1B 
Assessor demographics Assessments performed  
(n=184) 
Retrieval assessor’s grade  
   Junior trainee a  
   Senior trainee b 





  a ~3-6 years post-graduation, b >6 years post-graduation 















A 2x2 contingency table summarising the predictive performance of an independent 
transplant consultant compared to actual outcomes. A similar table describes the 
performance of CKAT assessments using the rule: “Carrel patch quality + Perfusion 





 Predicted by Consultants Sensitivity & 
Specification Decline Implant 
Actual 
Outcomes 
Declined 7 14 33% 
Implant 4 69 95% 
Positive and Negative 
Predictive Values 
63% 83%  
Assessments made using CKAT + assessment rule 
 Decision by CKAT rule Sensitivity & 
Specification Decline Accept 
Actual 
Outcomes 
Declined 9 12 47% 
Accept 1 72 99% 
Positive and Negative 
Predictive Values 











Materials provided to surgeons to record: 
A. Their overall assessment of the kidney’s suitability for transplantation 
B. Their assessment of the macroscopic appearance of the kidney using the 






Summary of standard (2A) and study (2B) appraisal pathways. In the standard 
appraisal pathway, a decision is made to retrieve the kidney based on the donor 
history and clinical information (including blood tests). These details are confirmed 
with the NORS team, who retrieve the kidney, assess it macroscopically, and return 
to the transplant centre with the organ. At the transplant centre, a further 
macroscopic assessment is made by the implanting surgeon during backbench 
preparation (green pathway) who then proceeds to implant the kidney or discards it. 
In the study pathway, two further assessments are made; a second independent 
consultant makes their own macroscopic assessment (orange pathway), and a 
transplant surgeon, typically part of the NORS team, uses the CKAT proforma to 
assess the kidney (purple pathway), the predictive power of these assessments are 






Frequency distribution bar chart showing the number of surgical assessments 
performed on each kidney in the series, the maximum number of assessments for a 






Frequency distribution bar charts summarising the scores given following surgical 











Box plots summarising the distribution of donor ages for each category of score 
given after assessment using the CKAT (Kruskal-Wallis significance test). Higher 
scores for carrel patch atherosclerosis and renal artery atherosclerosis appear to 
become restricted to an older cohort of donors, whilst good scores come from donors 






Box plots summarising the distribution of donor ages for each category of Remuzzi 
score assigned to those kidneys biopsied as part of routine transplant assessment 
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